Medigene AG
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
109 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
December 1, 2016 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Medigene AG by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 14, 2017 | Voleon Capital Management LP | 0.60% | |
| June 12, 2017 | Voleon Capital Management LP | 0.51% | |
| May 26, 2017 | Citadel Advisors II LLC | 0.60% | |
| May 24, 2017 | Citadel Advisors LLC | 0.50% | |
| May 24, 2017 | Citadel Advisors II LLC | 0.50% | |
| December 15, 2016 | Renaissance Technologies LLC | 0.48% | |
| December 8, 2016 | Renaissance Technologies LLC | 0.59% | |
| December 5, 2016 | Renaissance Technologies LLC | 0.68% | |
| December 1, 2016 | Renaissance Technologies LLC | 0.76% |
Download 109 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- HelloFresh SE 7.92% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- TUI AG 6.61% of the capital sold short
- PVA TePla AG 5.87% of the capital sold short
- Velo3D Inc 5.85% of the capital sold short
- Hugo Boss AG 5.63% of the capital sold short
- Puma SE 5.63% of the capital sold short
- K+S Aktiengesellschaft 5.53% of the capital sold short
- RENK Group AG 5.42% of the capital sold short
- Zalando SE 5.39% of the capital sold short
- Evotec SE 5.35% of the capital sold short
- Ocean Power Technologies, Inc 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Medigene AG, source Bundesanzeiger, data as at April 2, 2019, https://www.quivad.com/action/medigene-ag?page=3